In Practice

Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: Are they risk factors for disease severity?

O T Ezeokoli, C H Pohl

Abstract


Fungal co-infections, especially with Aspergillus and Candida species, are prevalent in hospitalised COVID-19 patients, and could influence patient outcomes and hamper treatment efforts. However, information about and elucidation of the causal relationship between fungal co-infections and COVID-19 disease outcomes or severity in patients are still lacking. Such information, if and when available, will help facilitate appropriate case management.


Authors' affiliations

O T Ezeokoli, Pathogenic Yeast Research Group, Department of Microbial, Biochemical and Food Biotechnology, Faculty of Natural and Agricultural Sciences, University of the Free State, Bloemfontein, South Africa

C H Pohl, Pathogenic Yeast Research Group, Department of Microbial, Biochemical and Food Biotechnology, Faculty of Natural and Agricultural Sciences, University of the Free State, Bloemfontein, South Africa

Full Text

PDF (149KB)

Keywords

COVID-19; Fungal co-infection; Disease severity; Candida species; Aspergillus species; Risk factors

Cite this article

South African Medical Journal 0;0(0):.

Article History

Date submitted: 2020-10-06
Date published: 2020-10-06

Article Views

Abstract views: 212
Full text views: 70

Comments on this article

*Read our policy for posting comments here